Human kidney map charts our growing immune defence
New cell atlas reveals immune cells present in zones of human kidney
The first cell atlas of the human kidney’s immune system has been created after scientists mapped nearly 70,000 individual kidney cells from early life and adults. Researchers at the Wellcome Sanger Institute, University of Cambridge, Newcastle University and their collaborators have generated the atlas and used it to map the communities of immune cells in the kidney. This shows for the first time how the immune system in our kidneys develops during early life in the womb, and strengthens after birth and as we mature into adults.
The results, published in Science, open the door to understanding how the kidney immune system works with important implications for tackling many types of kidney disease and transplant rejection.
The kidneys are two bean-shaped organs located below the rib cage that have an important role of filtering our blood. A pair of kidneys filter about half a cup of blood ever minute, removing waste and extra water which leaves the body as urine. They are critical in maintaining a healthy balance of water, salts and minerals in our blood, which enables our nerves, muscles and other tissues in the rest of the body to work properly*.
When the kidneys are damaged and can’t filter blood properly, they gradually lose function over time and patients develop chronic kidney disease. Chronic kidney disease affects more than 850 million people worldwide and is commonly caused by diabetes, high blood pressure and recurrent infection**. Unfortunately, chronic kidney disease can progress to kidney failure, which without dialysis or a kidney transplant, is fatal. The immune system plays a critical role in responding to kidney tissue damage, but very little is known about how this works in human kidneys.
To understand the immune system in the kidneys, what happens when tissue damage or infections occur, how this can lead to chronic kidney disease, and why kidney transplants are rejected, researchers created the first map of the kidney immune system.
The team were able to chart which types of immune cells were present in particular zones of the kidney at different stages of life – from early life in the womb to adult life.
“The kidney cell atlas allows us to chart where different types of immune cells are located in different zones of the kidney. We highlighted a strong defence zone at the base of the kidney, near where urine leaves the kidney via the ureter, which fights against urinary tract infections. Understanding how different cell types in a healthy kidney protects us against disease is important for tackling the development of chronic kidney disease and identifying new treatments.”
Professor Menna Clatworthy Co-lead author from the University of Cambridge Department of Medicine and Wellcome Sanger Institute
To create the kidney cell atlas during different development phases, researchers studied developmental§, child and adult kidney tissue. The team sequenced the activity of genes in 67,471 individual cells, using single-cell RNA sequencing, to pinpoint the types of immune cells present.
Scientists then mapped those cells over developmental time from early life to adult stage, and within the anatomical space of the kidney to understand how the kidney’s immune system develops and is organised.
Researchers discovered that the very earliest cells that populate the developing kidney are macrophages – large white blood cells that eat bad bacteria and viruses – which remain in the kidney as we grow older. There were few active immune cells in the developing kidney, which aligns with the view that a developing baby is relatively sterile and only encounters bacteria during and after birth, prompting the immune system to develop as we grow.
“We have created the first map showing how the immune system in the kidney develops in early life and how that changes as we mature into adults. We uncovered the very earliest cell types in the developing kidney – these macrophages that live in the kidney throughout life are important for protecting us against infection.”
Professor Muzlifah Haniffa Co-lead author from the Wellcome Sanger Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust
“The kidney cell atlas provides a window to understand what happens in diseases in children, including childhood kidney cancers. The atlas will allow researchers to ask fundamental questions about disease, like why some patients respond to treatment and others do not.”
Dr Sam Behjati Co-lead author from the Wellcome Sanger Institute and University of Cambridge
“Mapping the human kidney brings us one step closer to producing the Human Cell Atlas – a Google map of the 37 trillion cells in the human body. We will discover new cell types and uncover how our cells change over time, learn how and why we age and what happens when we get a disease. The Human Cell Atlas will be a free online resource, for anyone to use.”
Notes to Editors:
Data from this research is publically available on www.kidneycellatlas.org to enable further discoveries into kidney anatomy, development and function.
§ The developmental tissues were provided by the Wellcome- and MRC- funded Human Developmental Biological Resource (www.hdbr.org).
Benjamin Stewart et al. (2019) Spatio-temporal immune zonation of the human kidney. Science. DOI: 10.1126/science.aat5031
This study was supported by the St Baldrick’s Foundation, Wellcome, Cancer Research UK, the Cambridge Biomedical Research Campus, Cancer Research UK Cambridge Centre and others. For full funding information please refer to the publication.
The mission of the University of Cambridge is to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. To date, 107 affiliates of the University have won the Nobel Prize.
Founded in 1209, the University comprises 31 autonomous Colleges, which admit undergraduates and provide small-group tuition, and 150 departments, faculties and institutions. Cambridge is a global university. Its 19,000 student body includes 3,700 international students from 120 countries. Cambridge researchers collaborate with colleagues worldwide, and the University has established larger-scale partnerships in Asia, Africa and America.
The University sits at the heart of the ‘Cambridge cluster’, which employs 60,000 people and has in excess of £12 billion in turnover generated annually by the 4,700 knowledge-intensive firms in and around the city. The city publishes 341 patents per 100,000 residents. www.cam.ac.uk
Key facts about the University of Newcastle are available at https://www.ncl.ac.uk/press/about/keyfacts/
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
Related blog posts
15 May 2019
Caring for children with cancer
We explore the world of award-winning cancer scientist, Dr Sam Behjati
14 Sep 2021
Evidence-based national policies are essential to curb local COVID-19 infections
By using genomic surveillance and mobile phone data, researchers have uncovered useful insights into the management of the COVID-19 pandemic in ...
10 Sep 2021
Wellcome Sanger Institute recognised as Charity Times finalist for outstanding contribution to pandemic response
Staff praised for dedication and excellence as they work to sequence coronavirus genomes, helping to shape the pandemic response